Aethlon Medical, Inc.

Addressing Unmet Needs in Global Health

Novel Immunotherapies to Combat Cancer and Life-Threatening Viral Infections

Augmenting the Body's Natural Immune Defenses

The Aethlon Hemopurifier® is a first-in-class technology designed for the rapid depletion of cancer-promoting exosomes and circulating viruses. The United States Food and Drug Administration (FDA) has designated the Hemopurifier® as a “Breakthrough Device” for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease; and life-threatening viruses that are not addressed with approved therapies.

More About Our Hemopurifier®